Safety Publications Tool
Starting from 26 February 2024, for an AD published with no prior consultation as PAD (except for an Emergency AD), if any comments are received during the period of 28 days following the publication of that AD, EASA will publish a Comment Response Document (CRD) collecting EASA answers to those comments.
Please refer to the “Remarks” section of such ADs for instructions about how to send comments.
2021-06 : WITHDRAWN – RECOMMENDATIONS NOT NEEDED ANYMORE
EASA approval number
EASA Aircrew & Medical Department
/ Type Designation
Safety Information Bulletin
Publication(s) and related information
European Centre for Disease Prevention (ECDC) Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA. ECDC COVID-19 vaccination and prioritisation strategies in the EU/EEA. European Medicines Agency (EMA) Comirnaty EPAR -public assessment report. EMA Comirnaty - Procedural steps taken and scientific information after the authorisation. EMA COVID-19 vaccine Moderna- EPAR-public assessment report. EMA COVID-19 vaccine AstraZeneca - EPAR-public assessment report. World Health Organization (WHO) Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines. WHO COVID-19 vaccines technical documents.
Comments regarding this safety information should be referred to the Safety Information Section, Certification Directorate, EASA;
ADs [at] easa.europa [dot] eu
EASA_SIB_2021_06_withdrawn.pdf (756 kb)
For help on using this tool, please refer to
the help section
For any inquiry regarding ADs, please contact
the EASA AD team
To report any bug, broken link or problem with this application, please contact the
Disclaimer & copyright notice
- 2023 ©